+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Report By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2030- Product Image
Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Report By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2030- Product Image
New

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis Report By Type (Exocrine, Endocrine), By Treatment (Chemotherapy, Radiation Therapy, Others), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • PDF Icon

    Report

  • 100 Pages
  • August 2024
  • Region: Global
  • Grand View Research
  • ID: 5998873
Description Jump to:

Pancreatic Cancer Treatment Market Growth & Trends

The global pancreatic cancer treatment market size is expected to reach USD 6.98 billion by 2030, registering a CAGR of 13.9% during the forecast period. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Pancreatic Cancer Treatment Market Report Highlights

  • The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types.
  • Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells.
  • North America dominated the segment with the largest revenue share in 2023 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure.
  • Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Pancreatic Cancer Treatment Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Pancreatic Cancer Treatment Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. Pancreatic Cancer Treatment Market: By Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Pancreatic Cancer Treatment Market: By Type Analysis, 2024 & 2030 (USD Million)
4.3. Exocrine
4.3.1. Exocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Endocrine
4.4.1. Endocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Pancreatic Cancer Treatment Market: By Treatment Analysis, 2024 & 2030 (USD Million)
5.3. Chemotherapy
5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Radiation Therapy
5.4.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Pancreatic Cancer Treatment Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Pancreatic Cancer Treatment Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
6.3. Hospital Pharmacies
6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis
7.1. Pancreatic Cancer Treatment Market Share, By Region, 2024 & 2030, USD Million
7.2. North America
7.2.1. North America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. U.S. Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Canada Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.2.4. Mexico
7.2.4.1. Mexico Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. UK Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Germany Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. France Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Italy Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Spain Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Denmark Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.8. Norway
7.3.8.1. Norway Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3.9. Sweden
7.3.9.1. Sweden Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.2. China
7.4.2.1. China Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.3. Japan
7.4.3.1. Japan Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. India Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.5. South Korea
7.4.5.1. South Korea Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.6. Australia
7.4.6.1. Australia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4.7. Thailand
7.4.7.1. Thailand Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Brazil Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Argentina
7.5.3.1. Argentina Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
7.6.1. Middle East and Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.2. Saudi Arabia
7.6.2.1. Saudi Arabia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.3. UAE
7.6.3.1. UAE Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.4. Kuwait
7.6.4.1. Kuwait Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6.5. South Africa
7.6.5.1. South Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
8.4.1. AstraZeneca
8.4.1.1. Participant’s Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Recent Developments/ Strategic Initiatives
8.4.2. Novartis AG
8.4.2.1. Participant’s Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Recent Developments/ Strategic Initiatives
8.4.3. Pfizer Inc.
8.4.3.1. Participant’s Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Recent Developments/ Strategic Initiatives
8.4.4. Genentech, Inc.
8.4.4.1. Participant’s Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Recent Developments/ Strategic Initiatives
8.4.5. Bristol-Myers Squibb Company
8.4.5.1. Participant’s Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Recent Developments/ Strategic Initiatives
8.4.6. Ipsen Pharma
8.4.6.1. Participant’s Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Recent Developments/ Strategic Initiatives
8.4.7. Oncolytics Biotech Inc
8.4.7.1. Participant’s Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Recent Developments/ Strategic Initiatives
8.4.8. TME Pharma
8.4.8.1. Participant’s Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Recent Developments/ Strategic Initiatives
8.4.9. Phaxiam
8.4.9.1. Participant’s Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Recent Developments/ Strategic Initiatives

Companies Mentioned

  • AstraZeneca
  • Novartis AG
  • Pfizer Inc
  • Genentech, Inc
  • Bristol-Myers Squibb Company
  • Ipsen Pharma Oncolytics Biotech Inc
  • TME Pharma
  • Phaxiam

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages100
PublishedAugust 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 2.87 Billion
Forecasted Market Value ( USD ) by 2030 $ 6.98 Billion
Compound Annual Growth Rate13.9%
Regions CoveredGlobal
No. of Companies Mentioned8

Related Topics

Related Reports

Global Pancreatic Cancer Treatment Market by Affected region (Endocrine, Exocrine), Type (Chemotherapy, Targeted Therapy) - Forecast 2024-2030 - Product Image

Global Pancreatic Cancer Treatment Market by Affected region (Endocrine, Exocrine), Type (Chemotherapy, Targeted Therapy) - Forecast 2024-2030

  • Report
  • 180 Pages
  • Global
From
Global Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Forecast 2024-2030 - Product Image

Global Pancreatic Cancer Therapeutics Market by Type (Endocrine Pancreatic Cancer, Exocrine Pancreatic Cancer), Product (Chemotherapy, Gene Therapy, Immunotherapy), End-Use - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Pancreatic Cancer Diagnostic Market Size, Share & Trends Analysis Report By Product, By Test Type (Imaging Test, Biopsy, Blood Test, Others), By Cancer Type (Exocrine, Endocrine), By End-use, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 150 Pages
  • Global
From
Pancreatic Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Pancreatic Cancer Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 400 Pages
  • Global
From
Global Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034 - Product Image

Global Pancreatic Cancer Treatment Market Analysis & Forecast to 2024-2034

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.